PROMIS NEUROSCIENCES ($PMN) posted quarterly earnings results for Q2 2026 on Thursday, August 13th. The company reported earnings of -$1.28 per share, beating estimates of -$1.39 by $0.11. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $PMN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PROMIS NEUROSCIENCES Insider Trading Activity
PROMIS NEUROSCIENCES insiders have traded $PMN stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $PMN stock by insiders over the last 6 months:
- EUGENE WILLIAMS has made 4 purchases buying 6,000 shares for an estimated $141,220 and 0 sales.
- JOHANNE KAPLAN (Chief Development Officer) has made 2 purchases buying 3,909 shares for an estimated $55,329 and 0 sales.
- PATRICK D. KIRWIN purchased 4,000 shares for an estimated $45,320
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
PROMIS NEUROSCIENCES Hedge Fund Activity
We have seen 19 institutional investors add shares of PROMIS NEUROSCIENCES stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEEP TRACK CAPITAL, LP added 835,655 shares (+inf%) to their portfolio in Q1 2026, for an estimated $10,612,818
- WELLINGTON MANAGEMENT GROUP LLP added 696,378 shares (+inf%) to their portfolio in Q1 2026, for an estimated $8,844,000
- WOODLINE PARTNERS LP added 395,295 shares (+inf%) to their portfolio in Q1 2026, for an estimated $5,020,246
- YU FAN added 329,760 shares (+inf%) to their portfolio in Q1 2026, for an estimated $4,187,951
- SQUADRON CAPITAL MANAGEMENT LLC added 324,977 shares (+inf%) to their portfolio in Q1 2026, for an estimated $4,127,207
- SPHERA FUNDS MANAGEMENT LTD. added 313,784 shares (+2657.6%) to their portfolio in Q1 2026, for an estimated $3,985,056
- ALLY BRIDGE GROUP (NY) LLC added 164,880 shares (+66.1%) to their portfolio in Q1 2026, for an estimated $2,093,975
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
PROMIS NEUROSCIENCES Analyst Ratings
Wall Street analysts have issued reports on $PMN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 06/30/2026
To track analyst ratings and price targets for PROMIS NEUROSCIENCES, check out Quiver Quantitative's $PMN forecast page.
PROMIS NEUROSCIENCES Price Targets
Multiple analysts have issued price targets for $PMN recently. We have seen 2 analysts offer price targets for $PMN in the last 6 months, with a median target of $18.5.
Here are some recent targets:
- Boobalan Pachaiyappan from Roth Capital set a target price of $19.0 on 07/08/2026
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $18.0 on 06/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
